Atherosclerosis
Volume 211, Issue 1 , Pages 164-169 , July 2010

Serum adipocyte fatty acid-binding protein is independently associated with coronary atherosclerotic burden measured by intravascular ultrasound

  • Toru Miyoshi

      Affiliations

    • Department of Molecular Biology and Biochemistry, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, 2-5-1, Shikata-cho, Okayama 700-8558, Japan
    • Corresponding Author InformationCorresponding author. Tel.: +81 86 235 7129; fax: +81 86 222 7768.
    • ,
  • Go Onoue

      Affiliations

    • Department of Cardiovascular Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan
    • ,
  • Atsushi Hirohata

      Affiliations

    • Department of Cardiology, Sakakibara Heart Institute of Okayama, Okayama, Japan
    • ,
  • Satoshi Hirohata

      Affiliations

    • Department of Molecular Biology and Biochemistry, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, 2-5-1, Shikata-cho, Okayama 700-8558, Japan
    • ,
  • Shinichi Usui

      Affiliations

    • Department of Medical Technology, Okayama University Graduate School of Health Sciences, Okayama, Japan
    • ,
  • Kazuyoshi Hina

      Affiliations

    • Department of Cardiology, Sakakibara Heart Institute of Okayama, Okayama, Japan
    • ,
  • Hiroshi Kawamura

      Affiliations

    • Department of Cardiology, Sakakibara Heart Institute of Okayama, Okayama, Japan
    • ,
  • Masayuki Doi

      Affiliations

    • Department of Cardiology, Kagawa Prefectural Central Hospital, Kagawa, Japan
    • ,
  • Kengo Fukushima Kusano

      Affiliations

    • Department of Cardiovascular Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan
    • ,
  • Shozo Kusachi

      Affiliations

    • Department of Medical Technology, Okayama University Graduate School of Health Sciences, Okayama, Japan
    • ,
  • Yoshifumi Ninomiya

      Affiliations

    • Department of Molecular Biology and Biochemistry, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, 2-5-1, Shikata-cho, Okayama 700-8558, Japan

Received 6 August 2009 ,Revised 18 January 2010 ,Accepted 25 January 2010.

References 

  1. Matsuzawa Y, Nakamura T, Shimomura I, Kotani K. Visceral fat accumulation and cardiovascular disease. Obes Res. 1995;3(Suppl. 5):645S–647S
  2. Fortuno A, Rodriguez A, Gomez-Ambrosi J, Fruhbeck G, Diez J. Adipose tissue as an endocrine organ: role of leptin and adiponectin in the pathogenesis of cardiovascular diseases. J Physiol Biochem. 2003;59:51–60
  3. Makowski L, Hotamisligil GS. Fatty acid binding proteins—the evolutionary crossroads of inflammatory and metabolic responses. J Nutr. 2004;134:2464S–2468S
  4. Boord JB, Fazio S, Linton MF. Cytoplasmic fatty acid-binding proteins: emerging roles in metabolism and atherosclerosis. Curr Opin Lipidol. 2002;13:141–147
  5. Kazemi MR, McDonald CM, Shigenaga JK, Grunfeld C, Feingold KR. Adipocyte fatty acid-binding protein expression and lipid accumulation are increased during activation of murine macrophages by toll-like receptor agonists. Arterioscler Thromb Vasc Biol. 2005;25:1220–1224
  6. Hotamisligil GS, Johnson RS, Distel RJ, et al. Uncoupling of obesity from insulin resistance through a targeted mutation in aP2, the adipocyte fatty acid binding protein. Science. 1996;274:1377–1379
  7. Makowski L, Boord JB, Maeda K, et al. Lack of macrophage fatty-acid-binding protein aP2 protects mice deficient in apolipoprotein E against atherosclerosis. Nat Med. 2001;7:699–705
  8. Xu A, Wang Y, Xu JY, et al. Adipocyte fatty acid-binding protein is a plasma biomarker closely associated with obesity and metabolic syndrome. Clin Chem. 2006;52:405–413
  9. Tso AW, Xu A, Sham PC, et al. Serum adipocyte fatty acid binding protein as a new biomarker predicting the development of type 2 diabetes: a 10-year prospective study in a Chinese cohort. Diabetes Care. 2007;30:2667–2672
  10. Yeung DC, Xu A, Cheung CW, et al. Serum adipocyte fatty acid-binding protein levels were independently associated with carotid atherosclerosis. Arterioscler Thromb Vasc Biol. 2007;27:1796–1802
  11. Rhee EJ, Lee WY, Park CY, et al. The association of serum adipocyte fatty acid-binding protein with coronary artery disease in Korean adults. Eur J Endocrinol. 2009;160:165–172
  12. Cabre A, Lazaro I, Girona J, et al. Fatty acid binding protein 4 is increased in metabolic syndrome and with thiazolidinedione treatment in diabetic patients. Atherosclerosis. 2007;195:e150–158
  13. Mintz GS, Nissen SE, Anderson WD, et al. American College of Cardiology Clinical Expert Consensus Document on Standards for acquisition, measurement and reporting of intravascular ultrasound studies (IVUS). A report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents. J Am Coll Cardiol. 2001;37:1478–1492
  14. Nicholls SJ, Tuzcu EM, Crowe T, et al. Relationship between cardiovascular risk factors and atherosclerotic disease burden measured by intravascular ultrasound. J Am Coll Cardiol. 2006;47:1967–1975
  15. American Diabetes Association. Standards of medical care in diabetes—2008. Diabetes Care 2008;31(Suppl. 1):S12–54.
  16. Nissen SE, Yock P. Intravascular ultrasound: novel pathophysiological insights and current clinical applications. Circulation. 2001;103:604–616
  17. Makowski L, Brittingham KC, Reynolds JM, Suttles J, Hotamisligil GS. The fatty acid-binding protein, aP2, coordinates macrophage cholesterol trafficking and inflammatory activity. Macrophage expression of aP2 impacts peroxisome proliferator-activated receptor gamma and IkappaB kinase activities. J Biol Chem. 2005;280:12888–12895
  18. Tuncman G, Erbay E, Hom X, et al. A genetic variant at the fatty acid-binding protein aP2 locus reduces the risk for hypertriglyceridemia, type 2 diabetes, and cardiovascular disease. Proc Natl Acad Sci USA. 2006;103:6970–6975
  19. Furuhashi M, Tuncman G, Gorgun CZ, et al. Treatment of diabetes and atherosclerosis by inhibiting fatty-acid-binding protein aP2. Nature. 2007;447:959–965
  20. Fisher RM, Eriksson P, Hoffstedt J, et al. Fatty acid binding protein expression in different adipose tissue depots from lean and obese individuals. Diabetologia. 2001;44:1268–1273
  21. Fisher RM, Thorne A, Hamsten A, Arner P. Fatty acid binding protein expression in different human adipose tissue depots in relation to rates of lipolysis and insulin concentration in obese individuals. Mol Cell Biochem. 2002;239:95–100
  22. EUROASPIRE. A European Society of Cardiology survey of secondary prevention of coronary heart disease: principal results. EUROASPIRE Study Group. European action on secondary prevention through intervention to reduce events. Eur Heart J 1997;18:1569–82.
  23. Woodward M, Zhang X, Barzi F, et al. The effects of diabetes on the risks of major cardiovascular diseases and death in the Asia-Pacific region. Diabetes Care. 2003;26:360–366
  24. Yamamoto A, Richie G, Nakamura H, et al. Risk factors for coronary heart disease in the Japanese—comparison of the background of patients with acute coronary syndrome in the ASPAC study with data obtained from the general population. Asia-Pacific Collaboration on CHD Risk Factor Intervention study. J Atheroscler Thromb. 2002;9:191–199

PII: S0021-9150(10)00080-8

doi: 10.1016/j.atherosclerosis.2010.01.032

Atherosclerosis
Volume 211, Issue 1 , Pages 164-169 , July 2010

Article Tools

* Image Usage & Resolution